Biodiversity and bioseparation of HIV-1 envelope glycoproteins

被引：0

作者：

Shao, YM

Lu, YC

机构：

[1] Natl Ctr AIDS Prevent & Control, Beijing 100050, Peoples R China

[2] Inst Int Vaccine Dev, Cambridge, MA 02138 USA

[3] AVANT Immunotherapeut Inc, Needham, MA 02494 USA

来源：

CRITICAL REVIEWS IN ONCOGENESIS | 1999年 / 10卷 / 1-2期

关键词：

AIDS in developing countries; HIV-1; vaccine; envelope glycoprotein; biodiversity and bioseparation; phylogenetic analysis; molecular epidemiology; affinity chromatography; native gp120;

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Since 1984, studies from almost every branch of modern biology have filled in many gaps in our knowledge of human immunodeficiency virus type 1 (HIV-1). This review focuses on studies of biodiversity and bioseparation of HIV-1 envelope glycoproteins from the vaccine development point of view. It presents an updated picture of different systems for producing either native or recombinant HIV-1 envelope glycoproteins for the preparation of vaccine candidates. The prevention of HIV-1-associated disease is highly relevant to the abrogation of the neoplastic processes associated with this pathogen.

引用

页码：1 / 16

页数：16

共 50 条

[41] Comparative analysis of HIV-1 recombinant envelope glycoproteins from different culture systems
S A. Jeffs
S. Goriup
G. Stacey
C-T. Yuen
H. Holmes
[J]. Applied Microbiology and Biotechnology, 2006, 72 : 279 - 290
[42] Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins
Dey, Antu K.
David, Kathryn B.
Lu, Min
Moore, John P.
[J]. VIROLOGY, 2009, 385 (01) : 275 - 281
[43] Enhancing Sensitivity of HIV-1 to Antibody Neutralization by Modulating the Energy Landscape of the Envelope Glycoproteins
Johnson, Jacklyn
Zhai, Yinjie
Salimi, Hamid
Deleon, Orlando
Haim, Hillel
[J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 331 - 331
[44] INTERACTIONS OF HIV-1 AND HIV-2 ENVELOPE GLYCOPROTEINS WITH SULFATED POLYSACCHARIDES AND MANNOSE-6-PHOSPHATE
MBEMBA, E
GLUCKMAN, JC
GATTEGNO, L
[J]. GLYCOBIOLOGY, 1994, 4 (01) : 13 - 21
[45] Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4
Harrop, HA
Rider, CC
[J]. GLYCOBIOLOGY, 1998, 8 (02) : 131 - 137
[46] MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins
Takuya Tada
Yanzhao Zhang
Takayoshi Koyama
Minoru Tobiume
Yasuko Tsunetsugu-Yokota
Shoji Yamaoka
Hideaki Fujita
Kenzo Tokunaga
[J]. Nature Medicine, 2015, 21 : 1502 - 1507
[47] Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1
Jeffs, SA
Goriup, S
Kebble, B
Crane, D
Bolgiano, B
Sattentau, Q
Jones, S
Holmes, H
[J]. VACCINE, 2004, 22 (08) : 1032 - 1046
[48] The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization
Salimi, Hamid
Johnson, Jacklyn
Flores, Manuel G.
Zhang, Michael S.
O'Malley, Yunxia
Houtman, Jon C.
Schlievert, Patrick M.
Haim, Hillel
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (02) : 348 - 362
[49] Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins
Wilen, Craig B.
Parrish, Nicholas F.
Pfaff, Jennifer M.
Decker, Julie M.
Henning, Elizabeth A.
Haim, Hillel
Petersen, Josiah E.
Wojcechowskyj, Jason A.
Sodroski, Joseph
Haynes, Barton F.
Montefiori, David C.
Tilton, John C.
Shaw, George M.
Hahn, Beatrice H.
Doms, Robert W.
[J]. JOURNAL OF VIROLOGY, 2011, 85 (17) : 8514 - 8527
[50] Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates
Lee, SA
Orque, R
Escarpe, PA
Peterson, ML
Good, JW
Zaharias, EM
Berman, PW
Sheppard, HW
Shibata, R
[J]. VACCINE, 2001, 20 (3-4) : 563 - 576

← 1 2 3 4 5 →